Soiken Holdings Inc. (TYO:2385)
Japan · Delayed Price · Currency is JPY 224.00
-1.00 (-0.44%)
Aug 27, 2026, 1:55 PM JST
Soiken Holdings Financials Overview
Financials in millions JPY. Fiscal year is July - June.
Millions JPY. Fiscal year is Jul - Jun.
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Revenue Revenue Growth | 3,871 | 3,871 | 4,848 | 5,158 | 8,079 | 9,347 |
Revenue Growth | -20.15% | -20.15% | -6.01% | -36.16% | -13.57% | 4.53% |
Gross Profit Gross Profit Growth | 1,866 | 1,866 | 2,410 | 2,482 | 3,715 | 4,259 |
Operating Income Operating Income Growth | 275 | 275 | -138 | -610 | 725 | 1,208 |
Net Income Net Income Growth | 212 | 212 | -210 | -662 | 451 | 809 |
Earnings Per Share EPS Growth | 8.10 | 8.10 | -8.03 | -25.31 | 17.24 | 30.93 |
EPS Growth | - | - | - | - | -44.25% | 43.95% |
| Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| Period Ending | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Biological Evaluation System Biological Evaluation System Growth | 242.29 | 236.12 | 617.06 | 551.96 |
Health Care Support Health Care Support Growth | 688.31 | 594.76 | 553 | 548.81 |
Cosmetics Cosmetics Growth | 1,506 | 1,547 | 3,944 | 4,951 |
Health Food Supplement (Including Marketing) Health Food Supplement (Including Marketing) Growth | 2,140 | 2,505 | 2,491 | 2,736 |
Functionality Material Development Functionality Material Development Growth | 297.92 | 317.99 | 500.6 | 569.18 |
Unallocated Adjustment Unallocated Adjustment Growth | -26.49 | -42.54 | -24.78 | -9.39 |
Total Total Growth | 4,849 | 5,158 | 8,080 | 9,348 |
| Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Cash & Investments Cash & Investments Growth | 5,652 | 5,652 | 5,258 | 4,790 | 5,945 | 6,217 |
Total Debt Total Debt Growth | - | - | - | - | - | - |
Net Cash (Debt) Net Cash Growth | 5,652 | 5,652 | 5,258 | 4,790 | 5,945 | 6,217 |
Net Cash Growth | 7.49% | 7.49% | 9.77% | -19.43% | -4.38% | 46.11% |
Net Cash Per Share Net Cash Per Share Growth | 216.07 | 216.07 | 201.01 | 183.12 | 227.27 | 237.67 |
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Operating Cash Flow Operating Cash Flow Growth | 415 | 415 | 557 | -880 | -101 | 2,135 |
Capital Expenditures CapEx Growth | -38 | -38 | -37 | -11 | -29 | -11 |
Free Cash Flow Free Cash Flow Growth | 377 | 377 | 520 | -891 | -130 | 2,124 |
Free Cash Flow Growth | -27.50% | -27.50% | - | - | - | - |
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Gross Margin | 48.20% | 48.20% | 49.71% | 48.12% | 45.98% | 45.56% |
Operating Margin | 7.10% | 7.10% | -2.85% | -11.83% | 8.97% | 12.92% |
Pretax Margin | 5.94% | 5.94% | -4.52% | -11.90% | 8.95% | 13.38% |
Profit Margin | 5.48% | 5.48% | -4.33% | -12.83% | 5.58% | 8.65% |
FCF Margin | 9.74% | 9.74% | 10.73% | -17.27% | -1.61% | 22.72% |
| Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 27, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Dividend Per Share Dividend Per Share Growth | 10.000 | - | 5.000 | - | 5.000 | 5.000 |
Dividend Per Share Growth | 100.00% | - | - | - | 0% | 0% |
Dividend Yield | 4.54% | - | 3.10% | - | 1.79% | 1.62% |
| Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 27, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
PE Ratio | 27.76 | 26.28 | - | - | 17.40 | 10.86 |
Forward PE | - | 5.17 | 5.17 | 6.75 | 13.13 | 12.97 |
P/FCF Ratio | 15.61 | 14.78 | 8.45 | - | - | 4.14 |
PS Ratio | 1.52 | 1.44 | 0.91 | 0.85 | 0.97 | 0.94 |